Head and neck cancer

MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba - The Lancet, 2021 - thelancet.com
Head and neck cancer is the seventh most common type of cancer worldwide and comprise
of a diverse group of tumours affecting the upper aerodigestive tract. Although many different …

A review of curcumin and its derivatives as anticancer agents

MA Tomeh, R Hadianamrei, X Zhao - International journal of molecular …, 2019 - mdpi.com
Cancer is the second leading cause of death in the world and one of the major public health
problems. Despite the great advances in cancer therapy, the incidence and mortality rates of …

[HTML][HTML] The head and neck cancer immune landscape and its immunotherapeutic implications

R Mandal, Y Şenbabaoğlu, A Desrichard, JJ Havel… - JCI insight, 2016 - ncbi.nlm.nih.gov
Recent clinical trials have demonstrated a clear survival advantage in advanced head and
neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade …

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

TY Seiwert, Z Zuo, MK Keck, A Khattri… - Clinical cancer …, 2015 - AACR
Purpose: The genetic differences between human papilloma virus (HPV)–positive and–
negative head and neck squamous cell carcinomas (HNSCC) remain largely unknown. To …

Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC

JP Joseph, MK Harishankar, AA Pillai, A Devi - Oral oncology, 2018 - Elsevier
Hypoxia, a condition of low oxygen tension in tissues, has emerged as a crucial factor in
tumor pathophysiology. Hypoxic microenvironment gives rise to altered cellular metabolism …

Retinoic acid receptors: from molecular mechanisms to cancer therapy

A Di Masi, L Leboffe, E De Marinis, F Pagano… - Molecular aspects of …, 2015 - Elsevier
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

MK Keck, Z Zuo, A Khattri, TP Stricker, CD Brown… - Clinical cancer …, 2015 - AACR
Purpose: Current classification of head and neck squamous cell carcinomas (HNSCC)
based on anatomic site and stage fails to capture biologic heterogeneity or adequately …

[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a multinational, randomized study to compare radiotherapy
alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal …

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

JP Pignon, J Bourhis, C Domenge, L Designé - The Lancet, 2000 - thelancet.com
Background Despite more than 70 randomised trials, the effect of chemotherapy on non-
metastatic head and neck squamous-cell carcinoma remains uncertain. We did three meta …

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell …

DJ Adelstein, Y Li, GL Adams, H Wagner Jr… - Journal of clinical …, 2003 - ascopubs.org
Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the
benefit of adding chemotherapy to radiation in patients with unresectable squamous cell …